ISPC ISPECIMEN INC

iSpecimen Named to Fast Company’s World’s Most Innovative Companies Annual List for 2023

iSpecimen Named to Fast Company’s World’s Most Innovative Companies Annual List for 2023

Award Highlights Businesses at the Forefront of Innovation That Are Transforming Industries and Shaping Society

LEXINGTON, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: ISPC), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers (“iSpecimen”), has been named to Fast Company’s annual list of the as part of the biotech category for 2023. Fast Company is a business magazine that focuses on technology, business and design.

“Every day, healthcare institutions are throwing away valuable biospecimens they no longer need. However, what ends up disposed can actually serve as valuable resources for medical researchers in need of these types of biospecimens,” said Tracy Curley, CEO of iSpecimen. “Our team has worked tirelessly to solve this disconnect and eliminate the cumbersome and time-consuming process for researchers, who are our customers, to obtain this critical biomaterial. Being named to Fast Company’s World’s Most Innovative Companies list is a testament to our continued success in working to reinvent the biospecimen procurement process that will in turn help to further accelerate medical discovery.”

The iSpecimen Marketplace® allows life science researchers to search for and find millions of human biospecimens across iSpecimen’s global, proprietary network of healthcare providers, who have access to large, diverse patient populations and specimens. iSpecimen’s proprietary, cloud-based technology enables scientists to intuitively search via a Google-like search bar for biospecimens based on demographic traits, medical conditions, procedures, blood type, country of collection and much more.

iSpecimen addresses the highly fragmented and inefficient biospecimen procurement market that makes compliance and contracting increasingly complex and challenging for researchers to manage themselves. The iSpecimen Marketplace compliantly connects each side of this fragmented market to reduce the costs, time and risks for both suppliers and customers in the biospecimen supply chain.

The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. Fast Company will host its third annual on April 19-20, 2023. The virtual summit celebrates the Most Innovative Companies in business and provides an inside look at cutting-edge business trends and what it takes to innovate in 2023. Fast Company’s Most Innovative Companies issue (March/April 2023) is available online, as well as in-app form via iTunes, and on newsstands beginning March 14, 2023.

About iSpecimen

iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit .

For further information, please contact:

Investor Contact

KCSA Strategic Communications

Allison Soss

Media Contacts

KCSA Strategic Communications

Raquel Cona / Michaela Fawcett



EN
02/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ISPECIMEN INC

 PRESS RELEASE

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Privat...

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the...

 PRESS RELEASE

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Privat...

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market WOBURN, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered into a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses paya...

 PRESS RELEASE

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritte...

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical re...

 PRESS RELEASE

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritte...

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety. . (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with...

 PRESS RELEASE

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering WOBURN, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced underwritten public offering of 5,714,283 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.70 per share (the “Offering”). The aggregate...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch